Filtros de búsqueda

Lista de obras de

10-Year Outcomes in Localized Prostate Cancer

artículo científico publicado en 2017

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial

artículo científico publicado en 2004

A Bayesian multi-risks survival (MRS) model in the presence of double censorings

scientific article published on 28 January 2020

A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer

artículo científico publicado en 2019

A comparative study of rectal dose histograms in prostate brachytherapy: some analytic and numerical results

artículo científico publicado en 2005

A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization

scientific article published on 11 April 2006

A systematic review of hypofractionation for primary management of prostate cancer

artículo científico publicado en 2014

ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.

artículo científico publicado en 2017

ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer

artículo científico publicado en 2013

ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer

artículo científico publicado en 2014

ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer

artículo científico publicado en 2017

ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.

artículo científico publicado en 2016

ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.

artículo científico publicado en 2014

ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer

artículo científico publicado en 2016

Academic career selection and retention in radiation oncology: the Joint Center for Radiation Therapy experience

artículo científico publicado en 2007

Accurate Gleason grading of prostatic adenocarcinoma in prostate needle biopsies by general pathologists

artículo científico publicado en 2003

Active Surveillance Versus Treatment of Prostate Cancer: Should Metastasis Be the Primary End Point?

scientific article published on 27 February 2017

Active Surveillance for Low-Risk Prostate Cancer in Black Patients

artículo científico publicado en 2019

Activities and accomplishments of the cancer and leukemia group B genitourinary committee.

artículo científico publicado en 2006

Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization

artículo científico publicado en 2005

Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy

artículo científico publicado en 2005

Adjuvant Versus Salvage Post-Prostatectomy Radiation Therapy: A Critical Review of the Evidence ⬇️

artículo científico publicado el 18 de mayo de 2013

Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018

scientific article published on 30 April 2019

Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline Amendment 2018-2019

scientific article published on 08 August 2019

Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database

artículo científico publicado en 2007

Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death

artículo científico publicado en 2010

Adjuvant vs Salvage Radiation Therapy for High-Risk Prostate Cancer Following Radical Prostatectomy

artículo científico publicado en 2020

Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma

artículo científico publicado en 2003

Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate Cancer

scientific article published on 05 August 2019

Advancing age within established Gleason score categories and the risk of prostate cancer‐specific mortality (PCSM) ⬇️

artículo científico publicado el 1 de octubre de 2012

Adverse effects of androgen deprivation therapy and strategies to mitigate them.

artículo científico publicado en 2014

Age, Comorbidity, and the Risk of Prostate Cancer-Specific Mortality in Men With Biopsy Gleason Score 4+3: Implications on Patient Selection for Multiparametric MRI

artículo científico publicado en 2015

Alcohol Use Among Patients With Cancer and Survivors in the United States, 2000-2017

artículo científico publicado en 2020

American Cancer Society guideline for the early detection of prostate cancer: update 2010

artículo científico publicado en 2010

An image contrast agent selectively activated by prostate specific antigen

artículo científico publicado en 2005

Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality

artículo científico publicado en 2016

Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease

artículo científico publicado en 2015

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality

scientific article published on 09 October 2007

Androgen deprivation therapy use and risk of death in men treated with high-dose radiation for intermediate-risk prostate cancer

scientific article published on 18 May 2016

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

artículo científico

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology

artículo científico publicado en 2010

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.

artículo científico publicado en 2010

Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke

artículo científico publicado en 2010

Ask the doctor. A year ago, I had an orchiectomy for prostate cancer; my PSA is now 0.74. Not long afterward, I had two cardiac stents implanted. I still have some angina and shortness of breath. I started Ranexa a couple of weeks ago, which helps m

artículo científico publicado en 2010

Aspirin and hormone therapy for prostate cancer

artículo científico publicado en 2007

Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy

artículo científico publicado en 2012

Assessing a Prostate Cancer Brachytherapy Technique Using Early Patient-Reported Symptoms: A Potential Early Indicator for Technology Assessment?

artículo científico publicado en 2004

Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance

scientific article published on 01 November 2020

Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer

artículo científico publicado en 2018

Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate Cancer

scientific article published on 01 April 2020

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

artículo científico publicado en 2019

Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer

scientific article published on 01 June 2019

Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer.

artículo científico publicado en 2014

Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE.

artículo científico publicado en 2010

Author Reply

Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era

scientific article published on 01 July 2002

Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer

scientific article published on 01 December 2008

Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices

artículo científico

Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue

artículo científico publicado en 2004

Biopsy Gleason score and the duration of testosterone suppression among men treated with external beam radiation and 6 months of combined androgen blockade.

artículo científico publicado en 2012

Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer.

artículo científico publicado en 2017

Can short-term hormone therapy for rising PSA prolong survival?

artículo científico publicado en 2016

Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?

artículo científico publicado en 2003

Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015

artículo científico publicado en 2019

Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer

scientific article published on 01 December 2006

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

artículo científico publicado en 2003

Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer

artículo científico publicado en 2019

Cardiovascular Comorbidity and Mortality in Men With Prostate Cancer Treated With Brachytherapy-Based Radiation With or Without Hormonal Therapy ⬇️

artículo científico publicado el 16 de enero de 2013

Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer

artículo científico publicado en 2011

Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer

artículo científico publicado en 2008

Causes of death in men with prevalent diabetes and newly diagnosed high- versus favorable-risk prostate cancer

scientific article published on 30 October 2009

Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era

scientific article published on 01 October 2002

Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study

artículo científico publicado en 2018

Clinical decisions. Screening for prostate cancer

artículo científico publicado en 2012

Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA <or=10, and clinically localized prostate cancer

artículo científico publicado en 2003

Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer

scientific article published on 01 July 2002

Clinicopathologic and Molecular Characteristics of Prostate Cancer Diagnosed in Young Men Aged up to 45 Years

scientific article published on 11 December 2020

Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer

scientific article published on 09 October 2019

Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials

artículo científico publicado en 2008

Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial ⬇️

artículo científico publicado el 1 de febrero de 2011

Comorbidity and the Receipt of Curative Therapy for Favorable-risk Prostate Cancer Prior to and Following the Publication of PIVOT

artículo científico publicado en 2016

Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence

scientific article published on 01 February 2010

Comparative effectiveness of minimally invasive vs open radical prostatectomy.

artículo científico publicado en 2009

Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate

scientific article published on 01 December 2003

Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794.

artículo científico publicado en 2012

Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer.

artículo científico publicado en 2015

Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database

scientific article published on 28 June 2019

Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer: A Meta-analysis of Randomized Noninferiority Trials

artículo científico publicado en 2017

Coronary Artery Revascularization and the Risk of Death in Men With Prostate Cancer ⬇️

artículo científico publicado el 23 de julio de 2011

Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation ⬇️

artículo científico publicado el 31 de agosto de 2010

Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy: a decision analysis.

artículo científico publicado en 2013

Deciding which patients to treat with salvage radiotherapy after prostatectomy.

artículo científico publicado en 2010

Decipher Postprostatectomy: Is It Ready for Clinical Use?

artículo científico publicado en 2017

Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer

scientific article published on 01 November 2007

Defining a standard set of patient-centered outcomes for men with localized prostate cancer

artículo científico publicado en 2014

Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial

artículo científico publicado en 2013

Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate.

artículo científico publicado en 2007

Determinants of performing radical prostatectomy pelvic lymph node dissection and the number of lymph nodes removed in elderly men.

artículo científico publicado en 2010

Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer

artículo científico publicado en 2002

Diabetes Mellitus, Race and the Odds of High Grade Prostate Cancer in Men Treated With Radiation Therapy ⬇️

artículo científico publicado el 22 de octubre de 2011

Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: implications for the use of newer isotopes

scientific article published on 02 August 2013

Duration of Short-Course Androgen Suppression Therapy and the Risk of Death As a Result of Prostate Cancer

article

Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy

artículo científico publicado en 2007

Early Versus Delayed Initiation of Salvage Androgen Deprivation Therapy and Risk of Prostate Cancer-Specific Mortality

artículo científico publicado en 2018

Early detection of high‐grade prostate cancer using digital rectal examination (DRE) in men with a prostate‐specific antigen level of &lt;2.5 ng/mL and the risk of death ⬇️

artículo científico publicado el 3 de julio de 2012

Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial

artículo científico publicado en 2007

Effect of definition of preradiotherapy prostate-specific antigen velocity on its association with prostate cancer-specific mortality and all-cause mortality

artículo científico publicado en 2007

Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen

artículo científico publicado en 2003

Eighteen Months of Androgen Deprivation Therapy in Men with High-risk Prostate Cancer and the Risk of Death

artículo científico publicado en 2018

Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group

artículo científico publicado en 2004

Enabling hope

artículo científico publicado en 2020

Erectile function outcome reporting after clinically localized prostate cancer treatment

artículo científico publicado en 2007

Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened Cohort

artículo científico publicado en 2014

Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence

artículo científico publicado en 2009

Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapy

scientific article published on 10 January 2019

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation

scientific article published on 18 June 2020

Everything Happens for a Reason

artículo científico publicado en 2019

Evidence suggesting that obesity prevention measures may improve prostate cancer outcomes using data from a prospective randomized trial

artículo científico publicado en 2014

Evidence to support a continued stage migration and decrease in prostate cancer specific mortality

artículo científico publicado en 2006

Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era

artículo científico publicado en 2002

Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer

artículo científico publicado en 2020

FOAM ROLLING AND INDICES OF AUTONOMIC RECOVERY FOLLOWING EXERCISE-INDUCED MUSCLE DAMAGE

scientific article published on 01 May 2020

Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment

artículo científico publicado en 2004

Future of Treatment for Low-Risk Prostate Cancer: For All, for Some, or for None? ⬇️

artículo científico publicado el 4 de abril de 2011

Gene expression correlates of clinical prostate cancer behavior

article

Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.

artículo científico publicado en 2014

Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials

artículo científico publicado en 2009

Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer: The Risk of Death

artículo científico publicado en 2015

Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy

artículo científico publicado en 2007

Greatest Percentage Involved Core Length and Risk of Clinically Significant Prostate-Specific Antigen Failure After Radical Prostatectomy

artículo científico publicado en 2015

Greatest percentage of involved core length and the risk of death from prostate cancer in men with highest Gleason score ≥ 7

artículo científico publicado en 2014

Guideline for the management of clinically localized prostate cancer: 2007 update.

artículo científico publicado en 2007

Hormonal Therapy or External-Beam Radiation With Brachytherapy and the Risk of Death From Prostate Cancer in Men With Intermediate Risk Prostate Cancer ⬇️

artículo científico publicado el 29 de noviembre de 2011

Hormonal therapy and radiation for prostate cancer: is it safe?

artículo científico publicado en 2010

Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction

artículo científico publicado en 2009

How to compare results after surgery or radiation for localized prostate carcinoma

artículo científico publicado en 2002

Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer

artículo científico publicado en 2013

Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer

artículo científico publicado en 2006

Identifying patients at risk for significant versus clinically insignificant postoperative prostate-specific antigen failure

artículo científico publicado en 2005

Image contrast agents activated by prostate specific antigen (PSA).

artículo científico publicado en 2004

Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level

artículo científico publicado en 2006

Impact of multiple biopsy cores on predicting final tumor volume in prostate cancer detected by a single microscopic focus of cancer on biopsy

scientific article published on 01 August 2005

Impact of national guidelines on brachytherapy monotherapy practice patterns for prostate cancer

artículo científico publicado en 2013

Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death

artículo científico publicado en 2010

Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate

artículo científico publicado en 2002

Impact of the percentage of positive biopsy cores on the further stratification of primary grade 3 and grade 4 Gleason score 7 tumors in radical prostatectomy patients

artículo científico publicado en 2005

Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease

artículo científico publicado en 2004

Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer.

artículo científico publicado en 2018

Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy

artículo científico publicado en 2004

In reply to Froehner et al

artículo científico publicado en 2013

Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer

artículo científico publicado en 2020

Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction

artículo científico publicado en 2011

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

scientific article published on 01 June 2007

Influence of Comorbidity on the Risk of Mortality in Men With Unfavorable-Risk Prostate Cancer Undergoing High-Dose Radiation Therapy Alone

artículo científico publicado en 2016

Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer

scientific article published on 01 April 2007

Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma

artículo científico publicado en 2008

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

artículo científico publicado en 2002

Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer

artículo científico publicado en 2013

Innovations and Challenges in Prostate Cancer: Summary Statement for the 6th Cambridge Conference

article

Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure

artículo científico publicado en 2004

Intermediate-risk Prostate Cancer: Stratification and Management

artículo científico publicado en 2020

Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.

artículo científico publicado en 2009

Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors

artículo científico publicado en 2004

Is Gleason Grade 5 Prostate Cancer Resistant to Conventional Androgen Deprivation Therapy?

artículo científico publicado en 2015

Is long-term androgen suppression right for everyone with locally advanced prostate cancer? ⬇️

artículo científico publicado el 7 de octubre de 2010

Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known?

artículo científico publicado en 2008

Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis

scientific article published on 01 August 2002

Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy

artículo científico publicado en 2003

Localization of a portion of an endorectal balloon for prostate image-guided radiation therapy using cone-beam tomosynthesis: a feasibility study

artículo científico publicado en 2012

Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer

artículo científico publicado en 2015

Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancer

scientific article published on 05 July 2018

Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation

artículo científico publicado en 2011

Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials.

artículo científico publicado en 2017

Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. Or less

artículo científico publicado en 2002

Luteinizing-hormone releasing hormone therapy and the risk of death from Alzheimer disease

artículo científico publicado en 2010

Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study

scientific article published on 01 October 2007

Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer

artículo científico publicado en 2005

Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature

artículo científico

Mathematical rigor is necessary, but for men with prostate cancer, clinical relevance is the priority

artículo científico publicado en 2009

Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer

scientific article published on 01 November 2005

Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy

artículo científico publicado en 2014

Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy

artículo científico publicado en 2009

Models of care and NCCN guideline adherence in very-low-risk prostate cancer.

artículo científico publicado en 2013

Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy

artículo científico publicado en 2010

Motion and shape change when using an endorectal balloon during prostate radiation therapy

artículo científico publicado en 2006

Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.

artículo científico publicado en 2012

NCCN clinical practice guidelines in oncology: prostate cancer

artículo científico publicado en 2010

Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators

artículo científico

Neoadjuvant Hormonal Therapy Use and the Risk of Death in Men with Prostate Cancer Treated with Brachytherapy Who Have No or at Least a Single Risk Factor for Coronary Artery Disease ⬇️

artículo científico publicado el 7 de septiembre de 2012

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer

artículo científico publicado en 2014

Operating characteristics of prostate-specific antigen and verification bias

artículo científico publicado en 2005

Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer

artículo científico publicado en 2002

PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5.

artículo científico publicado en 2007

PSA outcome following radical prostatectomy for patients with localized prostate cancer stratified by prostatectomy findings and the preoperative PSA level

artículo científico publicado en 2005

PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate cancer aggressiveness

artículo científico publicado en 2008

Patient and treatment factors associated with complications after prostate brachytherapy

artículo científico publicado en 2006

Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature

artículo científico publicado en 2007

Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy

artículo científico publicado en 2005

Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study

artículo científico publicado en 2009

Patient‐reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial ⬇️

artículo científico publicado el 13 de abril de 2012

Pelvis Plus Prostate Radiation Therapy and the Risk of Death in Men With Newly Diagnosed Node-Positive Prostate Cancer

artículo científico publicado en 2015

Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?

artículo científico publicado en 2002

Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer

artículo científico publicado en 2006

Personalizing the Management of Men with Intermediate-risk Prostate Cancer ⬇️

artículo científico publicado el 26 de marzo de 2013

Personalizing the Use of Active Surveillance As an Initial Approach for Men With Newly Diagnosed Prostate Cancer

artículo científico publicado en 2015

Personalizing the duration of androgen-deprivation therapy use in the management of intermediate-risk prostate cancer

artículo científico publicado en 2014

Population-based determinants of radical prostatectomy surgical margin positivity.

artículo científico publicado en 2010

Post-Prostatectomy Radiation Therapy: Balancing Disease Control and Functional Outcomes

scientific article published on 16 December 2016

Post-operative salvage androgen deprivation and radiotherapy for prostate cancer

scientific article published on 16 October 2019

Posttreatment Prostate Specific Antigen Nadir Predicts Prostate Cancer Specific and All Cause Mortality

artículo científico publicado en 2012

Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer

artículo científico publicado en 2007

Predicting Life Expectancy in Men Diagnosed with Prostate Cancer

artículo científico publicado en 2015

Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database

artículo científico publicado en 2007

Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors

artículo científico publicado en 2008

Predicting prostate-specific antigen recurrence established: now, who will survive?

scientific article published on 01 August 2002

Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era.

artículo científico publicado en 2009

Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer

artículo científico publicado en 2002

Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer

scientific article published on 01 August 2006

Predictors of mortality after prostate-specific antigen failure

artículo científico publicado en 2006

Predictors of patient preferences and treatment choices for localized prostate cancer

artículo científico publicado en 2008

Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy

artículo científico publicado en 2005

Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy

artículo científico publicado en 2009

Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era

artículo científico publicado en 2005

Predictors of the use of supplemental androgen suppression therapy and external beam radiation in men with high-risk prostate cancer undergoing brachytherapy in community practice

artículo científico publicado en 2011

Preoperative 3-Tesla Multiparametric Endorectal Magnetic Resonance Imaging Findings and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men With Clinically Localized Prostate Cancer ⬇️

artículo científico publicado el 3 de octubre de 2012

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

artículo científico publicado en 2004

Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate cancer

scientific article published on 01 February 2006

Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy

artículo científico publicado en 2005

Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer

scientific article published on 01 November 2005

Pretreatment predictors of time to cancer specific death after prostate specific antigen failure

artículo científico publicado en 2003

Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer

artículo científico publicado en 2009

Prior-cancer diagnosis in men with nonmetastatic prostate cancer and the risk of prostate-cancer-specific and all-cause mortality

artículo científico publicado en 2014

Probiotic use and clindamycin-induced hypercholesterolemia.

artículo científico publicado en 2009

Progress and controversies: Radiation therapy for prostate cancer

artículo científico publicado en 2014

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

artículo científico publicado en 2019

Prostate Cancer: Where We Have Been, Where We Are, and Where We Are Going ⬇️

artículo científico publicado el 1 de julio de 2013

Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time

artículo científico publicado en 2008

Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012

scientific article published on 03 December 2019

Prostate cancer prevention and finasteride

artículo científico publicado en 2006

Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy

artículo científico publicado en 2010

Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors

artículo científico publicado en 2007

Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer

artículo científico publicado en 2010

Prostate cancer. Clinical practice guidelines in oncology

artículo científico publicado en 2007

Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy

scientific article published on 01 November 2004

Prostate specific antigen kinetics in the management of prostate cancer.

artículo científico publicado en 2008

Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial

artículo científico publicado en 2016

Prostate-Specific Antigen Velocity Before and After Elimination of Factors That Can Confound the Prostate-Specific Antigen Level ⬇️

artículo científico publicado el 2 de junio de 2011

Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis

scientific article published on 13 April 2019

Prostate-specific antigen (PSA) and PSA velocity: competitors or collaborators in the prediction of curable and clinically significant prostate cancer

artículo científico publicado en 2008

Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer

artículo científico publicado en 2004

Prostate-specific antigen level at initiation of hormonal therapy after prostate-specific antigen failure following prostatectomy or radiotherapy and therapeutic response

artículo científico publicado en 2007

Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure

artículo científico publicado en 2005

Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer

artículo científico publicado en 2006

Prostate-specific antigen response duration and risk of death for patients with hormone-refractory metastatic prostate cancer

artículo científico publicado en 2005

Prostate-specific antigen velocity and survival for patients with hormone-refractory metastatic prostate carcinoma

scientific article published on 01 January 2006

Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer

artículo científico publicado en 2007

Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality

artículo científico publicado en 2006

Provider Case Volume and Outcomes Following Prostate Brachytherapy

scientific article published on 13 November 2008

Quantifying the change in endorectal magnetic resonance imaging-defined tumor volume during neoadjuvant androgen suppression therapy in patients with prostate cancer

scientific article published on 01 September 2003

Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer

artículo científico publicado en 2004

Quantitative MR Imaging Assessment of Prostate Gland Deformation before and During MR Imaging–Guided Brachytherapy

article

Race and Survival Following Brachytherapy-Based Treatment for Men With Localized or Locally Advanced Adenocarcinoma of the Prostate ⬇️

artículo científico publicado el 20 de abril de 2011

Race and mortality risk after radiation therapy in men treated with or without androgen-suppression therapy for favorable-risk prostate cancer.

artículo científico publicado en 2016

Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.

artículo científico publicado en 2014

Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer

artículo científico publicado en 2014

Radiation Therapy for Prostate Cancer

scientific article published on 28 October 2019

Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer—Reply

artículo científico publicado en 2016

Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer

artículo científico publicado en 2002

Radiation with or without 6 months of androgen suppression therapy in intermediate- and high-risk clinically localized prostate cancer: a postrandomization analysis by risk group

artículo científico publicado en 2009

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer

artículo científico publicado en 2018

Radical prostatectomy for high-grade prostate cancer

scientific article published on 01 August 2006

Radical prostatectomy vs radiation therapy and androgen‐suppression therapy in high‐risk prostate cancer ⬇️

artículo científico publicado el 30 de abril de 2012

Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s).

artículo científico publicado en 2010

Re: Early detection of prostate cancer: AUA guideline: H. B. Carter, P. C. Albertsen, M. J. Barry, R. Etzioni, S. J. Freedland, K. L. Greene, L. Holmberg, P. Kantoff, B. R. Konety, M. H. Murad, D. F. Penson and A. L. Zietman J Urol 2013; 190: 419-42

artículo científico publicado en 2013

Re: Neal D. Shore, Fred Saad, Michael S. Cookson, et al. Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 2020;382:2187-96

artículo científico publicado en 2020

Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials

artículo científico publicado en 2010

Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone

scientific article published on January 2013

Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic

artículo científico publicado en 2020

Reply to D.E. Spratt

artículo científico publicado en 2017

Reply to K. Quan et Al, S.P. Collins et al, C.R. King et al, s. Arcangeli et al, d.B. Fuller, and D. Vordermark

scientific article published on 02 September 2014

Reply to M.C. Scholz et al

artículo científico publicado en 2016

Reply to Partial gland therapy for prostate cancer

scientific article published on 20 December 2018

Response to Drs Rogers, Hayes, and Demanes

artículo científico publicado en 2014

Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer

artículo científico publicado en 2015

Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men With Low or Intermediate Risk Disease ⬇️

artículo científico publicado el 14 de mayo de 2011

Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size

artículo científico publicado en 2010

Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease

artículo científico publicado en 2009

Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy

artículo científico publicado en 2008

Risk-Based Management of Prostate Cancer ⬇️

artículo científico publicado el 14 de julio de 2011

Salvage radiation in men after prostate-specific antigen failure and the risk of death

artículo científico publicado en 2011

Screening for familial and hereditary prostate cancer

artículo científico publicado en 2015

Screening for prostate carcinoma: prostate-specific antigen--friend or foe?

scientific article published on 01 March 2005

Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events

artículo científico publicado en 2002

Sequencing Treatments for Cancer During the COVID-19 Pandemic

artículo científico publicado en 2020

Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate

scientific article published on 01 May 2007

Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy

artículo científico publicado en 2015

Should all colorectal cancer patients over age 60 be screened for prostate cancer?

artículo científico publicado en 2013

Six-month androgen suppression plus radiation therapy compared with radiation therapy alone for men with prostate cancer and a rapidly increasing pretreatment prostate-specific antigen level

scientific article published on 01 September 2006

Statin use and the risk of prostate-specific antigen recurrence after radiation therapy with or without hormone therapy for prostate cancer

artículo científico publicado en 2010

Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: less cost at the expense of more genitourinary toxicity is a concerning but testable hypothesis

artículo científico publicado en 2014

Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality

scientific article published on 01 February 2019

Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial

artículo científico

Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer

artículo científico publicado en 2005

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

artículo científico publicado en 2003

Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials

article

Survival Following Radiation and Androgen Suppression Therapy for Prostate Cancer in Healthy Older Men: Implications for Screening Recommendations

artículo científico publicado en 2009

Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials

scientific article published on 01 April 2008

The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer.

artículo científico publicado en 2010

The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer

artículo científico publicado en 2009

The Effect of Foam Rolling on Recovery Between two Eight Hundred Metre Runs

artículo científico publicado en 2017

The Impact of Economic Recession on the Incidence and Treatment of Cancer

artículo científico publicado en 2015

The Number of High-Risk Factors and the Risk of Prostate Cancer–Specific Mortality After Brachytherapy: Implications for Treatment Selection ⬇️

artículo científico publicado el 31 de enero de 2012

The effect of differing Gleason scores at biopsy on the odds of upgrading and the risk of death from prostate cancer

artículo científico publicado en 2014

The impact of PSA and digital rectal examination on the risk of prostate cancer specific mortality in men with a PSA level <2.5 ng/ml

artículo científico publicado en 2014

The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma

artículo científico publicado en 2005

The impact of pathology review on treatment recommendations for patients with adenocarcinoma of the prostate

artículo científico publicado en 2004

The influence of serial prostate-specific antigen (PSA) screening on the PSA velocity at diagnosis

artículo científico publicado en 2008

The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease

artículo científico publicado en 2014

The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement

artículo científico publicado en 2010

Therapeutic strategies for localized and locally advanced prostate cancer: combining androgen suppression with definitive local therapy

scientific article published on 01 January 2003

Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment

artículo científico publicado en 2003

Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy

scientific article published on 04 May 2018

Time course and predictors of symptoms after primary prostate cancer therapy

artículo científico publicado en 2003

Time to Prostate-specific Antigen Nadir and the Risk of Death From Prostate Cancer Following Radiation and Androgen Deprivation Therapy

scientific article published on 18 January 2019

Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality

artículo científico publicado en 2007

Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality

scientific article published on 01 January 2008

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

artículo científico publicado en 2009

Timing of radiotherapy after radical prostatectomy

scientific article published on 28 September 2020

Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapy.

artículo científico publicado en 2009

Toward personalizing the use of androgen deprivation therapy to maximize benefit and minimize harm

artículo científico publicado en 2014

Toward the optimal use of androgen suppression therapy in the radiotherapeutic management of prostate cancer

scientific article published on 01 January 2007

Treatment or Monitoring for Early Prostate Cancer

artículo científico publicado en 2016

Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups

artículo científico publicado en 2014

Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study

artículo científico publicado en 2007

Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer ⬇️

artículo científico publicado el 21 de septiembre de 2011

US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun.

artículo científico publicado en 2013

Unfavorable Intermediate-Risk Prostate Cancer and the Odds of Upgrading to Gleason 8 or Higher at Prostatectomy

artículo científico publicado en 2016

Updated Results of Magnetic Resonance Imaging Guided Partial Prostate Brachytherapy for Favorable Risk Prostate Cancer: Implications for Focal Therapy ⬇️

artículo científico publicado el 15 de agosto de 2012

Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015

scientific article published on 01 February 2019

Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results

artículo científico publicado en 2014

Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy

scientific article published on 01 July 2002

Using patient-reported outcomes to assess and improve prostate cancer brachytherapy

artículo científico publicado en 2014

Using prostate-specific antigen doubling time in clinical practice

scientific article published on 19 May 2007

Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce

artículo científico publicado en 2002

Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy

artículo científico publicado en 2005

Utilization of multimodality therapy with primary radical prostatectomy versus radiation therapy for Gleason 8-10 prostate cancer

artículo científico publicado en 2020

Validity of Surrogate End Points for Prostate Cancer-Reply

artículo científico publicado en 2017

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in

artículo científico publicado en 2007

Volume of Gleason Pattern 4 Stratifies Risk of Metastasis and Death in Patients with Gleason Score 3+5=8/5+3=8 Positive Prostate Core Biopsies

artículo científico publicado en 2020

Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer.

artículo científico publicado en 2016

What the U.S. Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation ⬇️

artículo científico publicado el 17 de julio de 2012

When prostate brachytherapy fails: a case report and discussion

artículo científico publicado en 2005

Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy

artículo científico publicado en 2010

Who bears the greatest burden of aggressive treatment of indolent prostate cancer?

artículo científico publicado en 2015

Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk

artículo científico publicado en 2015

Workflow modeling and analysis of computer guided prostate brachytherapy under MR imaging control

scientific article published on 01 January 2004

p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda